SCHEMBL29638508

SCHEMBL29638508

Cc1ccc2c(Nc3ccc(CN(C)C)cc3)nccc2c1N1CN=C(N)c2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 8/20 0.35
LCK P06239 5/20 0.35
TEK Q02763 4/20 0.35
RAF1 P04049 2/20 0.34
KDR P35968 3/20 0.33
CYP1A2 P05177 4/20 0.32
CYP3A4 P08684 4/20 0.32
CYP2D6 P10635 4/20 0.32
CYP2C19 P33261 2/20 0.32
ALOX15 P16050 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
MAP4K4 O95819 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HSD17B10 Q99714 1/20 0.31
AURKA O14965 1/20 0.31
AURKB Q96GD4 1/20 0.31
INCENP Q9NQS7 1/20 0.31
TPX2 Q9ULW0 1/20 0.31
EGFR P00533 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638623 0.84 KDM1A (0.38) BRAFLCKTEKRAF1KDR
SCHEMBL29638749 0.79 BRAF (0.38) BRAFLCKTEKKDR
SCHEMBL29638645 0.79 BRAF (0.33) BRAFLCKTEKRAF1KDR
SCHEMBL26373249 0.77 BRAF (0.40) BRAFLCKTEKRAF1KDR
SCHEMBL29638490 0.76 MAPK14 (0.31) BRAFRAF1
SCHEMBL29638510 0.74 BRAF (0.47) BRAFLCKTEKRAF1KDR
SCHEMBL29638669 0.72 TNNI3K (0.35) KDRMAP4K4TDP1
SCHEMBL29638518 0.69 FGFR1 (0.36) BRAFRAF1KDRCYP1A2ALDH1A1
SCHEMBL25378146 0.68 RAB9A (0.37) BRAFLCKTEKRAF1CYP1A2
SCHEMBL29638578 0.67 RAF1 (0.43) BRAFRAF1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022089219-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-05-05 WO disclosed